Mutations to the SF3B1, U2AF1, SRSF2 and ZRSR2 genes regulating RNA splicing were detected in ~50% of patients with secondary MDS with ringed sideroblasts and in nearly 90% of patients with de novo MDS [60]. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.